Leptin, mild cognitive impairment, and dementia among elderly women

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 68, Issue 2, 2013, Pages 175-180

  Zeki Al Hazzouri, Adina ^a,b   Stone, Katie L ^c   Haan, Mary N ^a   Yaffe, Kristine ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

Dementia; Elderly; Leptin; Obesity

Indexed keywords

BIOLOGICAL MARKER; LEPTIN;

AGED; AGING; ARTICLE; BLOOD; BODY MASS; COHORT ANALYSIS; DEMENTIA; FEMALE; HUMAN; MILD COGNITIVE IMPAIRMENT; MULTICENTER STUDY; OBESITY; PATHOLOGY; PROSPECTIVE STUDY; RISK; RISK FACTOR; UNITED STATES;

AGED; AGED, 80 AND OVER; AGING; BIOLOGICAL MARKERS; BODY MASS INDEX; COHORT STUDIES; DEMENTIA; FEMALE; HUMANS; LEPTIN; MILD COGNITIVE IMPAIRMENT; OBESITY; ODDS RATIO; OVERWEIGHT; PROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES;

EID: 84871762341     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/gls155     Document Type: Article

References (40)

1. Dewey ME, Saz P. Dementia, cognitive impairment and mortality in persons aged 65 and over living in the community: a systematic review of the literature. Int J Geriatr Psychiatry. 2001;16(8):751-761. (Pubitemid 32834113)
2. Hendrie HC. Epidemiology of dementia and Alzheimer's disease. Am J Geriatr Psychiatr.1998;6(2Suppl 1):S3-S18.
3. Beydoun MA, Beydoun HA, Wang Y. Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis. Obesity Rev. 2008;9(3):204-218. (Pubitemid 351550691)
4. Whitmer RA, Gunderson EP, Barrett-Connor E, Quesenberry CP, Jr., Yaffe K. Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ. 2005;330(7504):1360.
5. Whitmer RA, Gunderson EP, Quesenberry CP, Jr., Zhou J, Yaffe K. Body mass index in midlife and risk of Alzheimer disease and vascular dementia. Curr Alzheimer Res. 2007;4(2):103-109. (Pubitemid 46557496)
6. Whitmer RA, Gustafson DR, Barrett-Connor E, Haan MN, Gunderson EP, Yaffe K. Central obesity and increased risk of dementia more than three decades later. Neurology. 2008;71(14):1057-1064.
7. Wannamethee SG, Shaper AG, Lennon L, Whincup PH. Decreased muscle mass and increased central adiposity are independently related to mortality in older men. Am J Clin Nutr. 2007;86(5):1339-1346. (Pubitemid 350126236)
8. Zafon C. Oscillations in total body fat content through life: an evolutionary perspective. Obesity Rev. 2007;8(6):525-530. (Pubitemid 47628489)
9. Baumgartner RN. Body composition in healthy aging. Ann NY Acad Sci. 2000;904:437-448. (Pubitemid 30389235)
10. Luchsinger JA, Patel B, Tang MX, Schupf N, Mayeux R. Measures of adiposity and dementia risk in elderly persons. Arch Neurol. 2007;64(3):392-398. (Pubitemid 46425695)
11. Elmquist JK, Maratos-Flier E, Saper CB, Flier JS. Unraveling the central nervous system pathways underlying responses to leptin. Nat Neurosci. 1998;1(6):445-450.
12. Harvey J. Leptin: a multifaceted hormone in the central nervous system. Mol Neurobiol. 2003;28(3):245-258. (Pubitemid 38156422)
13. Li XL, Aou S, Oomura Y, Hori N, Fukunaga K, Hori T. Impairment of long-term potentiation and spatial memory in leptin receptor-defcient rodents. Neuroscience. 2002;113(3):607-615. (Pubitemid 34874684)
14. Shanley LJ, Irving AJ, Harvey J. Leptin enhances NMDA receptor function and modulates hippocampal synaptic plasticity. J Neurosci. 2001;21(24):RC186.
15. Farr SA, Banks WA, Morley JE. Effects of leptin on memory processing. Peptides. 2006;27(6):1420-1425. (Pubitemid 43767004)
16. Fewlass DC, Noboa K, Pi-Sunyer FX, Johnston JM, Yan SD, Tezapsidis N. Obesity-related leptin regulates Alzheimer's Abeta. FASEB J. 2004;18(15):1870-1878. (Pubitemid 39602272)
17. Harvey J, Solovyova N, Irving A. Leptin and its role in hippocampal synaptic plasticity. Prog Lipid Res. 2006;45(5):369-378.
18. Beydoun MA, Beydoun HA, Shroff MR, Kitner-Triolo MH, Zonderman AB. Serum leptin, thyroxine and thyroid-stimulating hormone levels interact to affect cognitive function among US adults: evidence from a large representative survey. Neurobiol Aging. 2012; 33(8):1730-1743.
19. Holden KF, Lindquist K, Tylavsky FA, Rosano C, Harris TB, Yaffe K. Serum leptin level and cognition in the elderly: fndings from the Health ABC Study. Neurobiol Aging. 2009;30(9):1483-1489.
20. Lieb W, Beiser AS, Vasan RS, et al. Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging. JAMA. 2009;302(23):2565-2572.
21. Power DA, Noel J, Collins R, O'Neill D. Circulating leptin levels and weight loss in Alzheimer's disease patients. Dement Geriatr Cogn Disord. 2001;12(2):167-170. (Pubitemid 32149724)
22. Raji CA, Ho AJ, Parikshak NN, et al. Brain structure and obesity. Hum Brain Mapp. 2010;31(3):353-364.
23. Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 1996;334(5):292-295. (Pubitemid 26033933)
24. Arch Jr. Central regulation of energy balance: inputs, outputs and leptin resistance. Proc Nutr Soc. 2005;64(1):39-46. (Pubitemid 40685750)
25. Banks WA, Coon AB, Robinson SM, et al. Triglycerides induce leptin resistance at the blood-brain barrier. Diabetes. 2004;53(5):1253-1260. (Pubitemid 38569011)
26. Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med. 1995;332(12):767-773.
27. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV).Washington, DC: American Psychiatric Association;1994
28. Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol. 2001;58(12):1985-1992. (Pubitemid 33143977)
29. Yaffe K, Middleton LE, Lui LY, et al. Mild cognitive impairment, dementia, and their subtypes in oldest old women. Arch Neurol. 2011;68(5):631-636.
30. Lyness JM, Noel TK, Cox C, King DA, Conwell Y, Caine ED. Screening for depression in elderly primary care patients. A comparison of the Center for Epidemiologic Studies-Depression Scale and the Geriatric Depression Scale. Arch Intern Med. 1997;157(4):449-454. (Pubitemid 27089971)
31. SAS statistical software, release 9.2. [computer program] Cary, NC: SAS Institute; 2005 [computer program].
32. Harvey J, Shanley LJ, O'Malley D, Irving AJ. Leptin: a potential cognitive enhancer? Biochem Soc Trans. 2005;33(Pt5):1029-1032. (Pubitemid 41659106)
33. Gerges NZ, Aleisa AM, Alkadhi KA. Impaired long-term potentiation in obese zucker rats: possible involvement of presynaptic mechanism. Neuroscience. 2003;120(2):535-539. (Pubitemid 37288787)
34. Feng GS. Shp2 as a therapeutic target for leptin resistance and obesity. Expert Opin Ther Targets. 2006;10(1):135-142.
35. Steinberg GR, McAinch AJ, Chen MB, et al. The suppressor of cytokine signaling 3 inhibits leptin activation of AMP-kinase in cultured skeletal muscle of obese humans. J Clin Endocrinol Metabol. 2006;91(9):3592-3597. (Pubitemid 44402142)
36. Myers MG, Cowley MA, Munzberg H. Mechanisms of leptin action and leptin resistance. Annu Rev Physiol. 2008;70:537-556. (Pubitemid 351738191)
37. Chen K, Li F, Li J, et al. Induction of leptin resistance through direct interaction of C-reactive protein with leptin. Nat Med. 2006;12(4):425-432.
38. Gustafson D, Rothenberg E, Blennow K, Steen B, Skoog I. An 18-year follow-up of overweight and risk of Alzheimer disease. Arch Intern Med. 2003;163(13):1524-1528. (Pubitemid 36835095)
39. West NA, Haan MN. Body adiposity in late life and risk of dementia or cognitive impairment in a longitudinal community-based study. J Gerontol A Biol Sci Med Sci. 2009;64(1):103-109.
40. Fitzpatrick AL, Kuller LH, Lopez OL, et al. Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch Neurol. 2009;66(3):336-342.